Project Details
| Status | Active |
|---|---|
| Effective start/end date | 06/8/23 → 09/18/34 |
Funding
- Ascendis Pharma A/S: $110,273.25
AttaCH: A Phase 2, Multicenter, Long-Term, Open Label Extension Trial Evaluating Safety, Tolerability, and Efficacy of Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children and Adolescents with Achondroplasia
- Quattrin, Teresa (PI)
Project: Research